Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy,
New hope may be on the horizon for melanoma patients in the form of a novel skin cancer vaccine. This week, Moderna announced that its new vaccine has shown promising results in clinical trials. Among 157 patients with advanced melanoma, the vaccine
close Video New Jersey biotech company uses artificial intelligence for drug development PsychoGenics CEO Emer Leahy of Paramus, New Jersey, explains how the first potential AI-discovered treatment for schizophrenia was developed through machine learning. Fox News Digital spoke with her. Welcome to
Artificial intelligence is increasingly moving into the health care arena and helping to streamline medical processes — including the creation of new drugs. Insilico Medicine, an AI-driven biotech company based in Hong Kong and in New York City, recently announced that its
A shark’s menacing teeth can scare anyone out of the water — but one aspect of some sharks’ existence may be worth emulating: their ability to regrow teeth. An experimental medicine in Japan that could revolutionize the field of dentistry is now
The first-ever drug generated by artificial intelligence has entered Phase 2 clinical trials, with the first dose successfully administered to a human, Insilico Medicine announced yesterday. The drug, currently referred to as INS018_055, is being tested to treat idiopathic pulmonary fibrosis (IPF),
Britain’s health regulator said on Tuesday it would introduce new measures for faster and easier approval and execution of clinical trials in the country. The move comes months after an industry report showed that the number of annual clinical trials started in